Approval · Notice of Compliance 13093 · 2012
PMS-VALACYCLOVIR: Notice of Compliance 13093
Issued March 12, 2012
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 13093
- Date
- March 12, 2012
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- New strength
- Therapeutic class
- Antiviral Agent
- Canadian reference product
- VALTREX (Glaxosmithkline Inc)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-VALACYCLOVIR | 02381230 | Marketed |
Medicinal ingredients
- VALACYCLOVIR HYDROCHLORIDE 1,000 MG per TAB